Edwyn
Over the past five years, The Clorox Company’s revenue has remained relatively stable, fluctuating between roughly USD 7.1 billion and 7.4 billion. While the company experienced a slight decline from USD 7.34 billion in 2021 to USD 7.11 billion in 2022, revenues rebounded in 2023 to USD 7.39 billion before dipping again in 2024. Overall, these trends suggest a moderate level of revenue consistency in a consumer staples industry known for steady demand. Gross profit figures followed a similar pattern, declining from USD 3.20 billion in 2021 to USD 2.55 billion in 2022 before gradually recovering to USD 3.21 billion in 2025, indicating that underlying cost structures may be adjusting in line with market conditions, albeit with noticeable swings of over 20% in some comparisons. Net income, however, has been markedly more volatile. After a relatively healthy USD 710 million in 2021, net income dropped significantly to USD 462 million in 2022 and further plunged to only USD 149 million in 2023 – a nearly 68% drop from the previous year. Recovery began in 2024 with net income rising to USD 280 million, and by 2025, the company recorded a robust rebound to USD 810 million, effectively more than tripling the 2023 figure. These marked fluctuations in profitability could be driven by variations in cost management, product pricing, or other operational factors, although the operating income data remains unavailable for more detailed insight. In summary, while The Clorox Company’s top-line performance is stable, its net income volatility suggests a need to closely monitor cost structures and market dynamics to sustain long-term financial health.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.